Background illustration for clinical trials search

Triple Negative Breast Cancer Clinical Trials

Browse 2,256 triple negative breast cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

Study of FID-022 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumors
Location: Tampa FL, Duarte CA, Los Angeles CA
Sponsor: Fulgent Pharma LLC.

Sex: All

Age: 18+

Code: NCT06694480

Phase 1, Recruiting

GPC2-CAR T Cell Therapy for Relapsed or Refractory Medulloblastoma in Children and Young Adults

for
Medulloblastoma, Central Nervous System Embryonal Tumor,
Location: Palo Alto CA
Sponsor: Stanford University

Sex: All

Age: 1 - 30

Code: NCT07087002

Phase 1, Recruiting

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

for
HER2-positive Breast Cancer
Location: Norwich CT, Shirley NY, Quebec, Stony Brook NY,
Sponsor: Hoffmann-La Roche

Sex: All

Age: 18+

Code: NCT07413939

Phase 2, Phase 3, Recruiting

A Culturally Informed Patient Navigation Program (CFPN) to Reduce Delays Between Diagnosis and Treatment in American Indian and Alaska Native Cancer Patients Living in Rural California

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Bishop CA, Los Angeles CA
Sponsor: University of Southern California

Sex: All

Age: 0+

Code: NCT07332312

Recruiting

CUE-101with Pembrolizumab for Locally Advanced HPV+HNSCCs

for
Head and Neck Squamous Cell Carcinoma,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT07172256

Phase 2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their Body

for
Melanoma, Clear-Cell Renal-Cell Carcinoma (ccRCC),
Location: North Haven CT, Lake Success NY, Chapel Hill NC,
Sponsor: Regeneron Pharmaceuticals

Sex: All

Age: 18+

Code: NCT06413680

Phase 1, Phase 2, Recruiting

Window Study of Intratumoral Mitazalimab in Breast Cancer (WINIT-BC)

for
Breast Cancer
Location: Philadelphia PA
Sponsor: Jennifer Zhang

Sex: All

Age: 18+

Code: NCT07319195

Early Phase 1, Recruiting

Feasibility and Acceptability of Collecting Sociodemographic Data in CCTG Trials

for
Cancer
Location: Saint John, Quebec, Sherbrooke, Ottawa, Kingston,
Sponsor: Canadian Cancer Trials Group

Sex: All

Age: 18+

Code: NCT07390435

Recruiting

Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway

for
Cancer, Frail, Chemotherapy
Location: Winston-Salem NC, Charlotte NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 65+

Code: NCT07175376

Recruiting

Trial of Neoadjuvant THP vs TCHP for HER2-Amplified/Positive Breast Cancer

for
Breast Cancer
Location: Lee's Summit MO, Kansas City KS, Westwood KS,
Sponsor: University of Kansas Medical Center

Sex: All

Age: 18+

Code: NCT07220135

Phase 2, Recruiting

100-Year Human Aging Study

for
Aging, Aging Well, All-Cause Mortality, Mortality,
Location: Boulder CO
Sponsor: Longevity Metrics, Inc.

Sex: All

Age: 18+

Code: NCT07563777

Recruiting

Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis

for
Prostate Cancer, Breast Cancer, Lung Cancer, Ovarian Cancer,
Location: Bethesda MD
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 3+

Code: NCT01441089

Recruiting

Feasibility and Acceptibility of a Multi-site Trial of Time Restircted Eating During Chemotheraply for Breast Cancer.

for
Breast Cancer Early Stage Breast Cancer (Stage 1-3),
Location: Chicago IL
Sponsor: University of Illinois at Chicago

Sex: Female

Age: 25 - 70+

Code: NCT07387445

Recruiting

Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer

for
Breast Cancer - Infiltrating Ductal Carcinoma,
Location: Gresham OR, Vancouver WA, Portland OR, Tualatin OR
Sponsor: Legacy Health System

Sex: All

Age: 18+

Code: NCT07506876

Phase 2, Recruiting

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

for
Breast Neoplasm Female, Early Detection of Cancer,
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: Female

Age: 18 - 70+

Code: NCT06892275

Recruiting

AMG 410 Alone and in Combination With Other Agents in Participants With KRAS Altered Advanced or Metastatic Solid Tumors

for
KRAS Altered Advanced or Metastatic Solid Tumors
Location: Boston MA, Montreal, Philadelphia PA, Fairfax VA,
Sponsor: Amgen

Sex: All

Age: 18+

Code: NCT07094113

Phase 1, Recruiting

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

for
Advanced Solid Tumor
Location: Boston MA, Hartford CT, New Haven CT, New York NY,
Sponsor: BioNTech SE

Sex: All

Age: 18+

Code: NCT07070232

Phase 1, Phase 2, Recruiting

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

for
Endometrial Cancer, Malignant Solid Tumour
Location: Scarborough ME, Stony Brook NY, White Plains NY,
Sponsor: AstraZeneca

Sex: Female

Age: 18+

Code: NCT07044336

Phase 3, Recruiting

A Study of PHN-012 in Patients With Advanced Solid Tumors

for
Colon Cancer, Pancreatic Cancer, Lung Cancer (NSCLC),
Location: Boston MA, Washington D.C. DC, Fairfax VA, Durham NC,
Sponsor: Pheon Therapeutics

Sex: All

Age: 18+

Code: NCT07127874

Phase 1, Recruiting

Impact of Aromatase Inhibitor Therapy on Glucose Homeostasis and Diabetes Risk

for
HER2-Positive Breast Carcinoma
Location: Rochester MN
Sponsor: Mayo Clinic

Sex: Female

Age: 0+

Code: NCT06557057

Recruiting

What is triple negative breast cancer?

Triple negative breast cancer, or TNBC, is breast cancer whose cells test negative for estrogen receptors, progesterone receptors, and excess HER2 protein, so hormone therapy and HER2 targeted drugs do not work against it. It tends to grow faster and is more common in women who have not gone through menopause, in Black women, and in people with an inherited BRCA1 mutation, so genetic testing is recommended for everyone diagnosed. In US data, five year relative survival is about 92 percent when it is found while localized, 67 percent with regional spread, and 15 percent once it has reached distant organs. Standard treatment for early stage disease is chemotherapy combined with immunotherapy before surgery, followed by more treatment after; metastatic disease is treated with chemotherapy, immunotherapy for PD-L1 positive tumors, and antibody drug conjugates. Other breast cancers are covered on our breast cancer clinical trials page.

Types of triple negative breast cancer clinical trials

Who can participate in triple negative breast cancer clinical trials?

Is triple negative breast cancer hereditary?

Stages of triple negative breast cancer, and why they matter for trials

How to enroll in a triple negative breast cancer clinical trial